About Us

1919
Established
October 12
Milestones

¥997.3bn
Consolidated Revenue
March 2025
Company Outline

100
Diseases or Conditions Treated
*As of April 2025
Facts & Figures

40
Countries or Regions
*As of March 2025
Worldwide Office Locations
News
- Dec. 15, 2025 CorporateAn employee’s recovery from an esophageal disease through minimally invasive surgery — A “True to Life” Story
- Dec. 15, 2025 CorporateOlympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership
- Dec. 05, 2025 CorporateOlympus, Gore, and ConMed Announce Transition of Commercial Support for the GORE® VIABIL® Biliary Endoprosthesis in the United States
- Dec. 02, 2025 CorporateSwan EndoSurgical Appoints Veteran Robotics and MedTech Leader Erik Todd as Chief Executive Officer
- Oct. 21, 2025 CorporateOlympus: Feasibility Study on Endoscopy Infection Control Systems in India Selected for METI’s “Global South Co-Creation Subsidy Program”








